AstraZeneca Names New Head Of R&D | Chemical & Engineering News
Volume 93 Issue 34 | p. 15 | Concentrates
Issue Date: August 31, 2015

AstraZeneca Names New Head Of R&D

Department: Business
Keywords: drug discovery, clinical trials
[+]Enlarge
Bohen
Credit: AstraZeneca
Sean Bohen, who has been named executive vice president of global medicines development and chief medical officer at AstraZeneca. Bohen, a Ph.D. biochemist and physician, comes to the British drug company from Genentech.
 
Bohen
Credit: AstraZeneca

AstraZeneca has appointed Sean Bohen as head of global medicines development and chief medical officer. Bohen, a Ph.D. biochemist and physician, will come to the British drug company from Genentech, where he most recently headed early development and led efforts to incorporate diagnostics into clinical trials. AstraZeneca CEO Pascal Soriot notes that Bohen has extensive experience in oncology and immunology, two key areas in the company’s pipeline.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment